Resolution Of December 30, 2011, Of The General Directorate For Pharmacy And Medical Devices, That Correcting Errors In The 28 Of December Of 2011, By Which Determine The New Sets Of Medicines That Are Exempt In Offi...

Original Language Title: Resolución de 30 de diciembre de 2011, de la Dirección General de Farmacia y Productos Sanitarios, por la que se corrigen errores en la de 28 de diciembre de 2011, por la que se determinan los nuevos conjuntos de medicamentos que se dispensen en ofi...

Subscribe to a Global-Regulation Premium Membership Today!

Key Benefits:

Subscribe Now for only USD$20 per month, or Get a Day Pass for only USD$4.99.
Warned errors in the resolution of December 28, 2011, of the General Directorate for Pharmacy and medical devices, posted in the «Official Gazette», number 314, 30 of December of 2011, by which determine the new sets of medicines that are exempt in pharmacies through official prescription or order of dispensation , their reference prices, and reviewed the reference prices fixed by order SPI/3052/2010, of 26 November, and without it being altered the material content of the same, proceed to make the appropriate corrections: on the 145938 page, paragraph 3 of point 1 is amended as follows: where it says: «(3. Asimismo, en virtud de la potestad conferida por el párrafo segundo deel apartado 2.º y por el punto a) of paragraph 6 of the article» 93 of law 29/2006, of July 26, is set in 3.12 euros of retail price, including taxes, the minimum threshold for the prices of reference object of the present resolution."

It should say: "3. the minimum threshold for the prices of reference object of the present resolution is laid down in article 2 of the order SPI/3052/2010, November 26.»

On pages 145939 and 145940, point 7 is amended as follows: where it says: «7. coexistence of prices and return of inventories. "

1. stocks of presentations of drugs that in possession of stores affected by reductions in the prices provided for in this resolution, may continue to be marketed at the previous price until day 9 of March 2012 inclusive.

2. stocks of presentations of medicines that held by the pharmacy offices affected by the reductions provided for in this resolution, may continue to be marketed at the previous price until the day 31 March 2012 inclusive.

3. in the course of presentations of medicines that are part of inactive sets, the time limits referred to in the preceding paragraphs will be 70 calendar days for stores and natural pharmacies 90-day, and will be calculated from the time that notice be given by the General Directorate for Pharmacy and medical devices the express declaration refers to which paragraph 2 of the first additional provision of the Order SPI/3052/2010, November 26.

4 under cover in the article 6.2.5 of Royal Decree 726/1982, of 17 March, which regulates the expiration and returns of proprietary medicinal products to pharmaceutical, distribution warehouses and pharmacies, without additional cost to them, may be returned to the pharmaceutical laboratories, starting from the day following the expiry of the deadline referred to in paragraph two «, and pursuant to article 8 of the Royal Decree, stocks of presentations with price at the former packing to the reductions set out in this resolution.»

It must be said: «7. coexistence of prices and stock return.»

As to the coexistence of prices and the return of stocks of the presentations of drugs affected by price reductions provided for in this resolution, and that they held by the Department stores and the pharmacy offices, will have to comply with provisions of the fourth transitional provision of the order SPI/3052/2010, of 26 November «, since the present resolution produces its effects.»

Madrid, 30 of December of 2011.-the Director General of Pharmacy and products health, Maria Dolores cowboy Garcia.

Related Laws